Yuanzhe Li1,4, Hiroyo Yoshino2, Yutaka Oji1, Taku Hatano1, Manabu Funayama1,2, Nobutaka Hattori1,2,3 (1.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 2.Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Japan, 3.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan, 4.Department of Diagnosis, Prevention and Treatment of Dementia, Graduate School of Medicine, Juntendo University, Japan)
Session information
English Poster Session
English
[Pe-037] English Poster Session 037「Neurogenetics, Gene therapy, and iPS cell 2」
Thu. May 30, 2024 5:45 PM - 7:05 PM Poster (Hall E, E Block, B2F, TIF)
Chair(s): Yoshiki Adachi (National Hospital Organization Matsue Medical Center, Japan), Fumiaki Saito (Teikyo University, School of Medicine, Department of Neurology, Japan)
Hiroyo Yoshino1, Manabu Funayama1,2, Yuanzhe Li2,3, Mayu Ishiguro2, Aya Ikeda2, Kenya Nishioka2,4, Nobutaka Hattori1,2,3,5 (1.Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Japan, 2.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 3.Department of Diagnosis, Prevention and Treatment of Dementia, Graduate School of Medicine, Juntendo University, Japan, 4.Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, Japan, 5.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan)
Ikuko Mizuta1, Fumio Yamashita2,3, Akiko Watanabe-hosomi1, Atsushi Shimizu3,4, Shunji Mugikura5, Kengo Kinoshita6,7, Yoichi Sutoh3, Naoko Mori5, Makiko Taira6,8,9, Yayoi Otsuka-yamasaki3, Tomo Saito6, Hiraku Matsuura1, Akiko Miyazawa6, Hiroshi Sakamoto7, Masayuki Yamamoto7, Makoto Sasaki2,4, Nobuo Fuse6,7, Toshiki Mizuno1 (1.Dept. of Neurology, Kyoto Prefectural University of Medicine, Japan, 2.Div. of Ultrahigh Field MRI, Institute for Biomedical Sciences, Iwate Medical University, Japan, 3.Div. of Biomedical Information Analysis, Institute for Biomedical Sciences, Iwate Medical University, Japan, 4.Iwate Tohoku Medical Megabank Organization, Iwate Medical University, Japan, 5.Div. of Image Statistics, Tohoku Medical Megabank Organization, Tohoku University, Japan, 6.Dept. of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Japan, 7.Tohoku Medical Megabank Organization, Tohoku University, Japan, 8.Dept. of Neurology, Graduate School of Medicine, Tohoku University, Japan, 9.Dept. of Neurology, Tohoku University Hospital, Tohoku University, Japan)
Chiew Sern Ong (National Neuroscience Institute (NNI), Singapore)
Risako Nakai1,2, Mika Suga1,2, Keiko Imamura1,2,3, Takayuki Kondo1,2,3, Kayoko Tsukita1,2, Ran Shibukawa1, Yukako Sagara1, Le Minh1, Yuishin Izumi4, Kohji Mori5, Manabu Ikeda5, Kazuhiro Ishii6, Takashi Kimura7, Mitsuya Morita8, Ryosuke Takahashi9, Haruhisa Inoue1,2,3 (1.iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), Japan, 2.Department of Cell Growth and Differentiation, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 3.Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP), Japan, 4.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 5.Psychiatry, Graduate School of Medicine, Osaka University, Japan, 6.Department of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Japan, 7.Department of Neurology, Hyogo Medical University, Japan, 8.Division of Neurology, Department of Internal Medicine, Jichi Medical University, Japan, 9.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan)
Takahiro Hobara, Yujiro Higuchi, Masahiro Ando, Fumikazu Kojima, Akiko Yoshimura, Jun-hui Yuan, Yu Hiramatsu, Yusuke Sakiyama, Akihiro Hashiguchi, Hiroshi Takashima (Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Japan)